Celldex Therapeutics, Inc. Earnings

Celldex Therapeutics, Inc.’s revenue fell -93.62% since last year same period to $0.08Mn in the Q4 2025. On a quarterly growth basis, Celldex Therapeutics, Inc. has generated +Inf% jump in its revenue since last 3-months.

Celldex Therapeutics, Inc.’s net profit fell -72.77% since last year same period to $-81.36Mn in the Q4 2025. On a quarterly growth basis, Celldex Therapeutics, Inc. has generated -21.35% fall in its net profits since last 3-months.

Celldex Therapeutics, Inc.’s net profit margin fell -2606.7% since last year same period to -108480% in the Q4 2025. On a quarterly growth basis, Celldex Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Celldex Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1 - a -11.11% fall from last quarter’s estimates.

Celldex Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.

Celldex Therapeutics, Inc.’s earning per share (EPS) fell -71.83% since last year same period to -1.22 in the Q4 2025. This indicates that the Celldex Therapeutics, Inc. has generated -71.83% annual rate of fall in its earning per share (EPS) in the last 4 quarters.